Longevity start-up NOVOS closes $3.15m financing round

Latest articles

Exclusive: “Mitlets” hold potential for mitochondria transfusion

Mitrix Bio believes recently discovered blood components may support transfusion of large quantities of healthy mitochondria from donor to patient. Earlier this year, we brought...

Optimise your body and mind by tackling cell stress

Want to live longer and heathier? Combating cell stress is an important first step on your longevity journey. It's a fast-paced, busy world, and we're...

Crypto – pulling a (Moon) Rabbit out a hat for longevity

Angel Versetti on why it makes sense to look at more experimental solutions for longevity. Earlier this week we brought you part one of our...

New webinar will explore the opportunity of ovarian longevity

What does delaying menopause mean in terms of investment activity, societal change and the technologies that will reshape the lives of multiple millions of...

Most read

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Editor's picks

Exclusive: “Mitlets” hold potential for mitochondria transfusion

Mitrix Bio believes recently discovered blood components may support transfusion of large quantities of healthy mitochondria from donor to patient. Earlier this year, we brought...

Optimise your body and mind by tackling cell stress

Want to live longer and heathier? Combating cell stress is an important first step on your longevity journey. It's a fast-paced, busy world, and we're...

Crypto – pulling a (Moon) Rabbit out a hat for longevity

Angel Versetti on why it makes sense to look at more experimental solutions for longevity. Earlier this week we brought you part one of our...

Click the globe for translations.

Successful round for NOVOS sees longevity supplement company raise $3.15 million pre-seed to further its aim to extend healthy human lifespan with science-based supplements.

NOVOS, a company developing solutions for healthy aging and longevity, announced today the close of $3.15 million in pre-seed financing – apt timing for International Longevity Day! The 300% oversubscribed round was led by Resolute Ventures with support from Arkitekt Ventures, Longevitytech.fund, Awesome People Ventures and 20 institutional investors and entrepreneurs.

Longevity.Technology: New York-based NOVOS is a longevity platform offering science-based nutraceuticals, at-home tests and education to help people to improve their healthspans and lifespans. NOVOS closed its pre-seed round of $3.15 million in August 2021. The round was led by Mike Hirshland, Partner of Resolute Ventures. Hirshland has invested in dozens of successful companies, including Automattic (WordPress) and Bark, which IPO’d this year. He founded Dogpatch Labs, from which Instagram was launched.

It’s been a busy time for NOVOS who closed a friends-and-family round in late 2019, launched in October 2020 and hit the ground running, launching NOVOS Core and NOVOS Boost just a few months later. NOVOS Core is a novel longevity nutraceutical, containing 12 ingredients which are designed to target multiple hallmarks of aging, and which the NOVOS team believe work synergistically together to target healthspan and aging.

“The NOVOS founders are both driven by a mission to extend humanity’s healthspan. They bring a special combination of entrepreneurial strength and technical rigor. We are thrilled to welcome them to the Resolute family,” said Hirshland.

This round of funding will support the company’s rapid growth, power clinical research and propel the development of a leading longevity-focused platform during this pivotal time when the longevity market as a whole is experiencing a great deal of momentum globally.

NOVOS has enlisted an A list of longevity scientists and researchers with the aim of producing the most comprehensive, scientifically superior and evidence-based supplements on the market for those interested in longevity and optimal health, and counts George Church, João Pedro de Magalhães and Matt Kaeberlein among its scientific advisors.

“With this round of funding, we can work toward achieving our vision of being the world’s leading science-backed nutraceuticals brand by investing in longevity research that will have the most substantial impact on human health span and lifespan that we have seen in our lifetime,” said Chris Mirabile, founder and CEO of NOVOS.

Aging Mechanism Cellular Senescene
Aging Mechanism Cellular Senescene. Source: NOVOS

The longevity market currently has an estimated value of $25 trillion. As longevity is at the forefront of medicine and technology, it is considered to be the future of healthcare by some of the most highly-renowned scientists and technology leaders industry-wide. Given the significant momentum of the longevity industry, it’s wonderful to see the number of notable entrepreneurs and investors migrating to this sector and choosing to invest in companies like NOVOS. As scientific discoveries continue, this growth will continue to accelerate dramatically.

“Slowing aging and improving healthspan are not only major societal challenges but of great interest to most consumers. NOVOS is addressing these with a science-first approach and we are happy to be early backers of this multi-talented team!” said Dr Enke Bashllari, Managing Director, Arkitekt Ventures. 

More than 20 successful investors and entrepreneurs participated in the round, including:

  • Renaud Visage, co-founder of EventBrite
  • Matthew Cooper, chairman of Octopus Group, which invested £10 billion into innovative businesses that help to change the world
  • Lars Hinrichs, founder of XING and early investor in Facebook
  • Jerome Ternynck, founder and CEO of unicorn tech start-up, SmartRecruiters
  • Florian Gschwandtner, founder of Runtastic, acquired by Adidas for €220 million
  • Kağan Sümer and Ugur Samut, co-founders of Gorillas, Europe’s fastest growing unicorn start-up
  • Robin Haak, General Partner at Revaia.

The NOVOS strategy is to leverage a scientific approach to help consumers navigate the complex market of health and wellness supplements in order to extend lifespan and health span by combating cellular aging.

“In the past 10 years we’ve learned more about aging than in the 1,000 years prior. We are seeing outstanding progress in improving human health and slowing down aging via new technologies. NOVOS will continue to be at the forefront of these revolutions, and our platform a go-to source for those who aspire to live a long and healthy life,” said Kris Verburgh, MD, cofounder and Chief Scientific Officer of NOVOS.

 

Images courtesy of NOVOS
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Related articles

Crypto – pulling a (Moon) Rabbit out a hat for longevity

Angel Versetti on why it makes sense to look at more experimental solutions for longevity. Earlier this week we brought you part one of our...

New webinar will explore the opportunity of ovarian longevity

What does delaying menopause mean in terms of investment activity, societal change and the technologies that will reshape the lives of multiple millions of...

Buck Institute awarded $12.7m to join senescence network

NIH award to join SenNet, the Cellular Senescence Network, will enable Buck scientists to identify and characterise senescent cells – recognised as a driver...

Michael Antonov: longevity is all about tackling true unknowns

The Co-founder of Formic Ventures is using logic and innovation to drive the longevity sector forward. Michael Antonov is a serial entrepreneur and philanthropist who...

Shooting for the moon means going down the rabbit hole

Scientific co-operation, research collaboration and alternative financial incentives – Moon Rabbit is a crypto-conglomerate on a longevity mission. Moon Rabbit is on a mission to...